Clene Nanomedicine: Funding, Investors & Team (Oct 2026)
Clene Nanomedicine is a biopharmaceutical company in the clinical stage, primarily dedicated to creating innovative treatments for neurodegenerative disorders. They have devised a groundbreaking drug platform based on nanotechnology, allowing for the development of a brand-new category of orally-delivered neurotherapeutics.
Clene Nanomedicine has raised $103M across 4 funding rounds on record, the most recent an undisclosed round of $7.0M announced in May 2026.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Clene Nanomedicine Company Profile and Key Stats
Latest funding round on record: May 2026.
Clene Nanomedicine Funding Rounds
Clene Nanomedicine raised $22.4M in an undisclosed round announced in Dec 2020.
2.8 years later, an undisclosed round of $45.1M was announced in Oct 2023.
2.3 years later, an undisclosed round of $28.0M was announced in Jan 2026.
4 months later, an undisclosed round of $7.0M was announced in May 2026.
Clene Nanomedicine Founders and Leadership Team
Contact details for the Clene Nanomedicine team: 2 of 2 have an email address on file.
Start 14-day free trial →Clene Nanomedicine Funding Compared to Other Biotechnology Startups
Clene Nanomedicine's latest round of $7.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Clene Nanomedicine in Biotechnology and Salt Lake City
Companies Similar to Clene Nanomedicine
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Clene Nanomedicine Funding FAQs
What does Clene Nanomedicine do?
Clene Nanomedicine is a biopharmaceutical company in the clinical stage, primarily dedicated to creating innovative treatments for neurodegenerative disorders. They have devised a groundbreaking drug platform based on nanotechnology, allowing for the development of a brand-new category of orally-delivered neurotherapeutics.
How much funding has Clene Nanomedicine raised?
Clene Nanomedicine has raised $103M across 4 rounds on record. The most recent is an undisclosed round of $7.0M announced in May 2026.
When did Clene Nanomedicine last raise funding?
Clene Nanomedicine's most recent funding round on record is an undisclosed round of $7.0M, announced in May 2026.
Who founded Clene Nanomedicine?
FundedIQ lists Mark Mortenson (Founder) at Clene Nanomedicine.
Who is the CEO of Clene Nanomedicine?
Rob Etherington is listed as CEO at Clene Nanomedicine.
Where is Clene Nanomedicine headquartered?
Clene Nanomedicine is based in Salt Lake City, Utah, United States.
How many employees does Clene Nanomedicine have?
Clene Nanomedicine is in the 101-250 employee band.
How does Clene Nanomedicine's funding compare to other Biotechnology startups?
Clene Nanomedicine's latest round of $7.0M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Clene Nanomedicine Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Clene Nanomedicine is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.